RiceBran Technologies (RIBT)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
19.11.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECge Act. ☐         Item 5.02         Departure of Directors or Certain Officers   On November 15, 2024, David I. Chemerow

Stammdaten

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.

Unternehmen & Branche

NameRiceBran Technologies
TickerRIBT
CIK0001063537
BoerseUS
SektorConsumer Defensive
IndustriePackaged Foods
SIC2040 · Grain Mill Products

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung1.000 USD
Beta-0,90
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2024-03-3110-Q2,116,000-1,858,0005,054,000-4,732,000
2023-12-3110-K22,649,000-17,560,0009,322,000-3,000,000
2023-09-3010-Q4,857,000-1,782,00010,347,000-784,000
2023-06-3010-Q6,269,000-10,331,000-1.5411,365,000882,000
2023-03-3110-Q1,950,000-2,028,000-0.3126,551,00011,205,000
2022-12-3110-K26,647,000-7,858,000-1.4227,433,00012,909,000
2022-09-3010-Q6,637,000-2,042,000-0.3830,112,00013,203,000
2022-06-3010-Q6,581,000-2,621,000-0.5029,918,00014,751,000
2022-03-3110-Q10,559,000-1,516,000-0.2931,345,00017,225,000
2021-12-3110-K31,131,000-8,949,000-1.8731,313,00018,495,000
2021-09-3010-Q6,909,000-2,213,000-0.4734,739,00023,611,000
2021-06-3010-Q7,574,000-1,923,000-0.0432,660,00022,807,000
2021-03-3110-Q8,605,000591,0000.0135,078,00024,261,000
2020-12-3110-K26,199,000-11,730,000-0.2934,796,00023,420,000
2020-09-3010-Q5,160,000-2,774,000-0.0734,128,00023,473,000
2020-06-3010-Q5,903,000-3,949,000-0.1035,341,00025,389,000
2020-03-3110-Q8,330,000-3,033,000-0.0839,685,00029,022,000
2015-12-3110-K39,896,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×